当代医学
噹代醫學
당대의학
Contemporary Medicine
2015年
34期
142-143
,共2页
肺心病%心力衰竭%氯沙坦%卡托普利
肺心病%心力衰竭%氯沙坦%卡託普利
폐심병%심력쇠갈%록사탄%잡탁보리
Pulmonary heart failure%Congestive heart failure%Losartan%Captopril
目的 探讨氯沙坦联合卡托普利治疗肺心病心力衰竭的临床疗效.方法 选取肺心病心力衰竭的患者142例,随机分为对照组和观察组,各71例.对照组应用氯沙坦口服治疗,每次50mg,观察组应用氯沙坦和卡托普利联合治疗,氯沙坦钾片口服,每次50mg,每天1次.卡托普利每次1片,每天2次.30d后进行疗效比较观察.结果 观察组显效32例(45.07%),有效36例(50.71%),无效3例(4.23%),总有效率为95.77%.对照组显效29例(40.85%),有效30例(42.25%),无效12例(16.90%),总有效率为83.10%.2组总有效率比较,差异有统计学意义(χ2=6.038,P=0.014).结论 应用氯沙坦联合卡托普利治疗肺心病心力衰竭,不仅可以提高治疗效果,而且可以明显减轻患者痛苦,值得临床推广应用.
目的 探討氯沙坦聯閤卡託普利治療肺心病心力衰竭的臨床療效.方法 選取肺心病心力衰竭的患者142例,隨機分為對照組和觀察組,各71例.對照組應用氯沙坦口服治療,每次50mg,觀察組應用氯沙坦和卡託普利聯閤治療,氯沙坦鉀片口服,每次50mg,每天1次.卡託普利每次1片,每天2次.30d後進行療效比較觀察.結果 觀察組顯效32例(45.07%),有效36例(50.71%),無效3例(4.23%),總有效率為95.77%.對照組顯效29例(40.85%),有效30例(42.25%),無效12例(16.90%),總有效率為83.10%.2組總有效率比較,差異有統計學意義(χ2=6.038,P=0.014).結論 應用氯沙坦聯閤卡託普利治療肺心病心力衰竭,不僅可以提高治療效果,而且可以明顯減輕患者痛苦,值得臨床推廣應用.
목적 탐토록사탄연합잡탁보리치료폐심병심력쇠갈적림상료효.방법 선취폐심병심력쇠갈적환자142례,수궤분위대조조화관찰조,각71례.대조조응용록사탄구복치료,매차50mg,관찰조응용록사탄화잡탁보리연합치료,록사탄갑편구복,매차50mg,매천1차.잡탁보리매차1편,매천2차.30d후진행료효비교관찰.결과 관찰조현효32례(45.07%),유효36례(50.71%),무효3례(4.23%),총유효솔위95.77%.대조조현효29례(40.85%),유효30례(42.25%),무효12례(16.90%),총유효솔위83.10%.2조총유효솔비교,차이유통계학의의(χ2=6.038,P=0.014).결론 응용록사탄연합잡탁보리치료폐심병심력쇠갈,불부가이제고치료효과,이차가이명현감경환자통고,치득림상추엄응용.
Objective To investigate the effect of patients with pulmonary heart disease combined congestive heart failure treated by losartan and captopril.Methods 142 patients with pulmonary heart diseasecombined congestive heart failure were randomly divided into control group and observation group, each group was 71 eases. The control group were given losartan,while the observation group were given losartan and captopril. The effects of the two groups were compared after 30 days.Results The effective treatment in 32 cases (45.07%), valid in 36 cases (50.71%),invalid in 3 cases (4.23%) in observation group,the total effective rate was 95.77%.The effective 29 cases (40.85%),valid in 30 cases (42.25%),invalid in 12 cases (16.90%) in control group,the total effective ratewas83.10%. was significant difference in effective rate between two groups (χ2=6.038, P=0.014).Conclusion Losartan and captopril in treatment of pulmonary heart disease combined congestive heart failure in treating can not only enhance the treatment effect, and can significantly reduce pain, and worthy of clinical application.
